Diffusion Pharmaceuticals DFFN

$ 4.4 11.68%

Quarterly report 2024-Q3
added 11-12-2024

Diffusion Pharmaceuticals EV/EBITDA Ratio 2011-2024 | DFFN

Annual EV/EBITDA Ratio Diffusion Pharmaceuticals

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-52.4	-2.74	0.992	0.0883	0.0337	-1.83	-	-3.08	-1.57	-39.2	-4.27

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
0.992	-52.4	-10.4